✗ Close categories
Animals
Apple
Apps & Smartphones
Arts
Business
Cars
Celebrities
Child Care
Christianity
Conspiracy theories
✗ Close categories
Animals Apple Apps & Smartphones Arts Business Cars Celebrities Child Care Christianity Conspiracy theories✗ Close categories
✗ Close categories
Formula 1 - McLaren Videos
Formula 1 - Mercedes AMG Petronas Videos
Formula 1 - Sauber F1 Team Videos
Formula 1 - Scuderia Ferrari Videos
Formula 1 - Scuderia Toro Rosso Videos
Formula 1 - Team Lotus Videos
✗ Close categories
Formula 1 - McLaren Videos Formula 1 - Mercedes AMG Petronas Videos Formula 1 - Sauber F1 Team Videos Formula 1 - Scuderia Ferrari Videos Formula 1 - Scuderia Toro Rosso Videos Formula 1 - Team Lotus Videos✗ Close categories
✗ Close categories
Adelaide
Albany
Albury
Alice Springs
Armidale
Bacchus Marsh
Bairnsdale
Ballarat
Ballina
Barwon Downs
Batemans Bay
Bathurst
Bendigo
Blaxland
Bongaree
Bowral
Brisbane
Broken Hill
Broome
Buderim
Bunbury
Bundaberg
Burnie
Busselton
Byron Bay
Caboolture
Cairns
Caloundra
Canberra
Casino
Central Coast
Cessnock
Coffs Harbour
Colac
Craigieburn
Cranbourne
Dalby
Darwin
Devonport
Drouin
Dubbo
Echuca
Emerald
Forbes
Gawler
Geelong
Geraldton
Gladstone
Gold Coast
Goulburn
Grafton
Griffith
Gympie
Hamilton
Hervey Bay
Hobart
Horsham
Kalgoorlie
Karratha
Katoomba
Kawana
Kempsey
Kiama
Kingaroy
Kingston
Kwinana Town Centre
Launceston
Lismore
Lithgow
Mackay
Maitland
Mandurah
Maroochydore
Maryborough
Melbourne
Melton
Mildura
Moe
Mornington
Morwell
Mount Eliza
Mount Gambier
Mount Isa
Mount Martha
Mudgee
Murray Bridge
Muswellbrook
Nambour
Nerang
Newcastle
Nowra
Orange
Pakenham
Palmerston
Parkes
Perth
Port Augusta
Port Hedland
Port Lincoln
Port Macquarie
Port Pirie
Portland
Queanbeyan
Raymond Terrace
Redcliffe
Richmond
Rockhampton
Rockingham
Rosebud
Sale
Sawtell
Shepparton
Singleton
Sunbury
Sunshine Coast
Swan Hill
Sydney
Tamworth
Taree
Toowoomba
Townsville
Traralgon
Ulverstone
Victor Harbor
Victoria Point
Wagga Wagga
Wangaratta
Warragul
Warrnambool
Warwick
Whyalla
Wodonga
Wollongong
✗ Close categories
Adelaide Albany Albury Alice Springs Armidale Bacchus Marsh Bairnsdale Ballarat Ballina Barwon Downs Batemans Bay Bathurst Bendigo Blaxland Bongaree Bowral Brisbane Broken Hill Broome Buderim Bunbury Bundaberg Burnie Busselton Byron Bay Caboolture Cairns Caloundra Canberra Casino Central Coast Cessnock Coffs Harbour Colac Craigieburn Cranbourne Dalby Darwin Devonport Drouin Dubbo Echuca Emerald Forbes Gawler Geelong Geraldton Gladstone Gold Coast Goulburn Grafton Griffith Gympie Hamilton Hervey Bay Hobart Horsham Kalgoorlie Karratha Katoomba Kawana Kempsey Kiama Kingaroy Kingston Kwinana Town Centre Launceston Lismore Lithgow Mackay Maitland Mandurah Maroochydore Maryborough Melbourne Melton Mildura Moe Mornington Morwell Mount Eliza Mount Gambier Mount Isa Mount Martha Mudgee Murray Bridge Muswellbrook Nambour Nerang Newcastle Nowra Orange Pakenham Palmerston Parkes Perth Port Augusta Port Hedland Port Lincoln Port Macquarie Port Pirie Portland Queanbeyan Raymond Terrace Redcliffe Richmond Rockhampton Rockingham Rosebud Sale Sawtell Shepparton Singleton Sunbury Sunshine Coast Swan Hill Sydney Tamworth Taree Toowoomba Townsville Traralgon Ulverstone Victor Harbor Victoria Point Wagga Wagga Wangaratta Warragul Warrnambool Warwick Whyalla Wodonga Wollongong✗ Close categories
-
Sydney man becomes cryonics facility's first client, with hopes he will eventually be brought back to life
via abc.net.au
An unexpected dying request has resulted in a Sydney man being cryogenically frozen in a groundbreaking Australian move.
-
Seedless mangoes could be around the corner, but are shoppers willing to pay for them?
via abc.net.au
Demand for seedless fruit is growing and the technology needed to create new varieties is improving rapidly, but some in the industry say "the price point just hasn't been there" to convince farmers to grow them.
-
How a croc bite, and quick thinking, could make for a world-beating pain relief remedy
via abc.net.au
When John Watson was bitten by a crocodile, he knew exactly which plant would help his wound. Scientists now think that plant could lead to a powerful pain relief gel.
-
Elon Musk's Neuralink gets approval to start clinical trials implanting chips in human brains
via abc.net.au
Elon Musk's brain-implant company Neuralink says it has received a green light from the US Food and Drug Administration (FDA) to kickstart its first-in-human clinical study, a critical milestone after earlier struggles to gain approval.
-
These robots are built using biology from insects — the creators say it's a game changer
via abc.net.au
Scientists at an Adelaide university reverse-engineer the biology of insects to create a robot that can understand vision it is capturing from a camera.
-
Halfway between Brisbane and the Gold Coast, this city wants to be the next Silicon Valley. Here's how
via abc.net.au
Logan, population 350,000, is one of Australia's fastest-growing cities. But for many who live there, a daily commute north to Brisbane or south to the Gold Coast for work is the norm something Logan City Council wants to change by attracting tech companies and start-ups.
-
Pearl-to-bone project hopes to inspire northern Australia tech boom
via abc.net.au
Not just for decoration, pearl shells have potential for use in orthopaedic devices and other health products, including as a synthetic bone substitute.
-
App screening coughs for COVID receives promising early trial results
via abc.net.au
A smartphone app with the ability to detect COVID-19 from the sound of a cough is a step closer after promising early trial results, a Brisbane digital health company says.
-
'It's a disaster': Australian RAT producers slam governments for dragging their feet on at-home testing
via abc.net.au
As Australians struggle to get their hands on mainly imported COVID-19 rapid antigen tests, several Australian companies have been waiting months for local approval to sell their RATs.
-
Australian-made RATs await TGA approval amid supply shortage
via abc.net.au
As Australians struggle to get their hands on mainly imported COVID-19 rapid antigen tests, several Australian companies have been waiting months for local approval to sell their RATs.
-
Australian-made RATs await TGA approval amid rapid antigen test shortage
via abc.net.au
As Australians struggle to get their hands on mainly imported COVID-19 rapid antigen tests, several Australian companies have been waiting months for local approval to sell their RATs.
-
Sleep apnoea going undiagnosed as current tests miss 'the full story', study finds
via abc.net.au
A new sleep tracker reveals up to 50 per cent of people with mild or moderate sleep apnoea could be misdiagnosed under current clinical testing, researchers say.
-
How a 'cracker program' teaching girls to weld is widening career options
via abc.net.au
Australia's skills shortage in male-dominated trades could be solved by women, according to the organisers of a new program teaching welding skills to schoolgirls.
-
Elizabeth Holmes goes on trial for Theranos scandal
via abc.net.au
She was once the world’s youngest self-made female billionaire and a Silicon Valley rising star. Now, she’s the defendant in America’s trial of the year.
-
How should we treat insects?
via abc.net.au
Insect farming, we’re told by its proponents, is the next big thing in edible protein production, and it may just save the environment. But an insect “farm” is more like a manufacturing plant, where tiny organisms are frozen, boiled, baked, crushed or shredded alive in their billions. What is the moral status of these living things? Can we be sure they’re not sentient beings, capable of experiencing pain and suffering? And if we can’t be sure, how should we treat th
-
Pfizer, AZ and Moderna have dominated the globe. But Australia's 'next generation' COVID-19 vaccines offer something different
via abc.net.au
As mutant strains of the COVID-19 continue to appear, scientists and researchers are working feverishly behind the scenes to find the next vaccines. And Australia is part of the search.
-
'Chasing the mutants': The Australian researchers searching for 'next generation' COVID-19 vaccines
via abc.net.au
As mutant strains of the COVID-19 continue to appear, scientists and researchers are working feverishly behind the scenes to find the next vaccines. And Australia is part of the search.
-
Bill and Melinda Gates agree to divide their assets, but exactly who gets what is uncertain
via abc.net.au
Bill and Melinda Gates are splitting up, and it is unclear how the foundation they built together, focusing on global health projects, will operate or who will get how much of their shared billions.
-
Australian AstraZeneca manufacturer still committed to make 50 million vaccine doses
via abc.net.au
The Australian manufacturer of the AstraZeneca COVID-19 vaccine says it still plans to fill a federal government order of 50 million doses, despite health authorities recommending a different vaccine be preferred for those under 50 years of age.
-
Why big tech literally wants to read your mind
via abc.net.au
Tech companies are investing millions with the hope of creating a future where thought-controlled technology is everywhere. It offers hope to people with paralysis, but ethicists are worried where it could lead.
-
The thought-controlled technology that has big tech excited
via abc.net.au
Tech companies are investing millions with the hope of creating a future where thought-controlled technology is everywhere. It offers hope to people with paralysis, but ethicists are worried where it could lead.
-
The thought-controlled tech that has Facebook and Elon Musk excited, and ethicists worried
via abc.net.au
Tech companies are investing millions with the hope of creating a future where thought-controlled technology is everywhere. It offers hope to people with paralysis, but ethicists are worried where it could lead.
-
Scientist extracts dried coronavirus samples from bank notes
via abc.net.au
CSIRO researchers have found the virus can survive for up to 28 days on common surfaces.
-
You may never have heard of him, but Andrew Barkla was Australia's highest-paid CEO in 2019
via abc.net.au
With a pay cheque of almost $38 million, IDP Education's Andrew Barkla earned about 420 times the average full-time wage.
-
First Australian-made COVID swabs a promising sign for local manufacturers
via abc.net.au
They are a crucial frontline tool in the fight against coronavirus and now one Sydney company has become the first to sell locally-made medical swabs.
-
First Aussie-made COVID swabs reveals manufacturing pivot
via abc.net.au
A tiny company has become the first to sell Australian-made swabs for COVID-19 testing in a promising sign for local manufacturers.
-
A promising coronavirus vaccine and a $200 million profit. Now for the bad news
via abc.net.au
Imagine a biotech company is progressing well with its coronavirus vaccine, shares soar in value, company execs dump them and take a 600 per cent profit. Is it legal and what are the ramifications for research? David Taylor explains.
-
Tech stocks soar as the world stays indoors, but will it all come crashing down?
via abc.net.au
Tech stocks in Australia and the US have not only recovered to pre-COVID highs, they have surpassed them. But some say the rally is reminiscent of the dot-com boom and bust.
-
Tech stock bubble warnings rise amid coronavirus rally
via abc.net.au
Tech stocks in Australia and the US have not only recovered to pre-COVID highs, they have surpassed them. But some say the rally is reminiscent of the dot-com boom and bust.
-
Renewed Australian motor industry to be fuelled by low-emission hydrogen cars
via abc.net.au
Ambitious plans to assemble hydrogen electric hybrid vehicles in the Illawarra have been greeted with cautious optimism.
-
Could sugarcane regions pioneer a bioplastics industry?
via abc.net.au
A North Queensland politician says bioplastics could meet a demand for eco-wrapping and boost farmers' income, but the industry and researchers say it's not a simple feat.
-
Could farmers fuel the next stage of renewables?
via abc.net.au
The emerging bioenergy industry could play a fundamental role in Australian agriculture meeting its $100 billion value by 2030 and also help New South Wales achieve its target of zero net emissions by 2050.
-
How we're getting through this
via abc.net.au
Coronavirus is changing the way the entire human race lives.
Emergency workers are scrambling together contingency plans, fearing hospitals could soon be overwhelmed.
Scientists are racing to invent a faster, cheaper Covid-19 test kit available for us all.
Restaurants are reinventing themselves as delivery services, artists are turning to live-streaming to make a living.
This week, the entire Background Briefing team investigates how each of us are finding new ways to get by.
-
CBA's falling profit and CSL's gains highlight differing fortunes of banks and biotech
via abc.net.au
Two of Australia's largest companies have revealed diverging fortunes, with the Commonwealth Bank's cash profit falling, while biotech giant CSL has reported another six months of strong growth.
-
Biotech giant CSL close to overtaking CBA as profit reports confirm diverging fortunes
via abc.net.au
Two of Australia's largest companies have revealed diverging fortunes, with the Commonwealth Bank's cash profit falling, while biotech giant CSL has reported another six months of strong growth.
-
Australian biotech industry struggling to keep innovations out of foreign hands
via abc.net.au
The Australian medical research and development industry punches above its weight, but much of its intellectual property is being sold overseas so it can become commercially viable.
-
A biotech firm is about to pass the Commonwealth Bank as Australia's second biggest company
via abc.net.au
The Australian medical research and development industry punches above its weight, but much of its intellectual property is being sold overseas so it can become commercially viable.
-
The radical experimenters: a rapper, a poet, and a biological artist
via abc.net.au
The poetic cosmos drips with mango juice. Pigs might fly when porcine cells are your paint and wings your canvas. Rap lyrics that challenge science denialism. Artists pushing at the boundaries of the imagination and the possibilities of science.
-
Patient Storytelling: There’s an Art to it!
After 30-plus years working in Washington DC, it’s clear healthcare decision makers recognize that a patient’s story can add value to a discussion when data cannot.
While the value of data is not disputed, the art of patient storytelling is seldom discussed. I believe this is partly due to the desire that patients’ experiences be respected, not questioned, or confronted in the same manner policies are debated. There’s also a desire not to cherry-pick the patie
-
Could the Lifesaving Promises of Golden Rice FINALLY be Realized?
On this page we usually tout the newest examples of biotechnology innovation: jet fuels made from algae; gene edited bananas that resist disease; soil microbes that reduce the need for chemical inputs like fertilizer; and bio-based products that are more environmentally friendly. The list of next generation innovation goes on and on with inspirational stories of biotech’s promise to improve our planet, our society and our economy.
Sadly, after two decades, there remain technologies in the
-
CMS’s Own Data Do NOT Support Claims on Part B Drug Spending
In a story entitled, “CMS Blames Medicare Part B Hikes on Drug Costs,” writers for Politico Pulse note:
“The agency [Centers for Medicare & Medicaid Services] on Friday announced a $9 monthly premium increase and $13 annual deductible hike, but argued that the White House is working to bring down cost drivers for seniors.
“The increase in the Part B premiums and deductible is largely due to rising spending on physician-administered drugs,” CMS said in its announ
-
In Speaker Pelosi’s Extreme Drug Pricing Bill, Funding for NIH is MIA
Supporters of Speaker Pelosi’s extreme drug pricing bill (H.R. 3) want us to believe that they can destroy the biopharmaceutical industry and still produce new cures and treatments for patients in need. The crux of this fairy tale is the promise by supporters of H.R. 3 to reinvest “savings” from the bill back into the National Institutes of Health (NIH). But there are two significant problems with this empty promise.
Problem #1: H.R. 3 does NOT reinvest savings back into the NI
-
Synthetic Biology to Sustain Agriculture and Transform the Food System
For some, the term “synthetic biology” can bring back nightmares of the infamous college course that all students failed at least one. But what was once a roadblock to receiving a bachelors degree in science, is quickly turning into a robust field of biotechnology that is showing potential to transform how we manufacture products and grow food.
Synthetic biology can be used to develop renewable chemicals to create products like synthetic rubber for tires or bioplastics
-
GMOs and Animal Feed – Getting the Facts
People have a lot of questions about GMOs. One of the top questions people have is about GMOs in the grocery store. But most people don’t know that much of the GMO crop production around the world goes to helping feed animals. In fact, genetically modified crops have benefited the livestock sector by helping to increase yields of the crop, having higher quality traits, and are safer for livestock to eat than feed in the past. The GMO crops that are used in animal feed and p
-
Expanding Benefits to Members, BIO Now Offering Education and Training Courses
BIO is continually looking for ways to help its members grow and prosper. This week BIO announced a partnership with Biotech Primer Inc.—a training organization helping professionals understand the science, business, and regulatory processes essential to the biotech industry. Since its start in 2001, Biotech Primer has trained over 65,000 life science professionals worldwide.
Biotech Primer and BIO are joining forces to offer online training/education to the BIO Membership community and bi
-
The Pelosi Plan and “Me Too” Drugs
Supporters of Speaker Pelosi’s drug pricing plan (H.R. 3) claim the bill will discourage the development of so-called “me too” drugs. For example, Rep. Donna Shalala was recently quoted as saying: “I think it actually will reduce me-too drugs … I think [pharmaceutical companies] are going to clean their portfolios. … I think that they’ll become more efficient.” There’s just one problem: HR 3 is designed to have the opposite effect
-
#BIOSummit19 Concludes with Message of Hope Offered by Innovation
Representing all facets of the patient stakeholder community, participants in BIO’s eighth Patient and Health Advocacy Summit (#BIOSummit19) came together to proclaim: “I am BIO.” But as Dr. Julie Gerberding, executive vice president and chief patent officer at Merck and Co., who acted as the event’s chief convener, added: “I am BIO, but we need BIO.”
“We’re poised on the precipice of scientific possibility, there’s enormous potential for sci
-
Australia is rich but unsophisticated, says Harvard. But is it true?
via abc.net.auA recent Harvard study found Australia's economy is less complex than Kazakhstan or Uganda, but is the assessment fair? And, if it is, what can be done to diversify the economy away from its mining dependence?
-
FDA Discusses Effective Patient Engagement at #BIOSummit19
For the FDA, engagement with patients, caregivers and patient advocacy organizations is a vital part of the drug development and review process. However, how that engagement happens can determine how successful it is.
This was the key question addressed by the “Practices and Principles: Navigating the FDA” panel on day one of BIO’s Patient and Health Advocacy Summit.
“It’s really been heartening to see the ways that not just the FDA but industry is inco
-
#BIOSummit19: Education and Partnerships Raise Awareness
When Mark Dant’s son Ryan was first diagnosed with MPS-I, a rare genetic disorder that leads to organ damage, he had to buy a medical dictionary in order to decipher the words the doctors were saying to him.
“I didn’t understand the language of the scientists,” Dant recalled. “The key for every advocate is education. Once I was able to understand the basic terminology, I was able to ask the right questions. It’s not someone else’s responsibility to teach
Follow @Biotech_News_AU on Twitter!